Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tyrosine kinase inhibitor
Pharma
Merck and Eisai call it quits on drug combo trial in melanoma
Merck and Eisai's Keytruda-Lenvima cocktail has had a rough time in the clinic, with the pair's latest flop tanking a trial in melanoma.
Fraiser Kansteiner
Apr 7, 2023 9:43am
Novartis wins CML nod for new Gleevec follow-on Scemblix
Nov 1, 2021 6:51am
Takeda will not sign off on trial which could repurpose drug
Sep 15, 2021 7:37am
Is Keytruda-Lenvima the winner in kidney cancer?
Feb 17, 2021 4:08pm
Opdivo, Cabometyx in FDA fast lane for kidney nod
Oct 20, 2020 9:42am
BMS, Exelixis combo slashes kidney cancer death risk 40%
Sep 19, 2020 12:30pm